Immune response - BCR pathway

Click on a target from the pathway image to view related information. Zoom     View Legend

photo_map
 


Human PrimePCR Selections
photo_fpc
BCR Pathway H96

Predesigned 96-well panel for use with SYBR® Green

 

List Price:  $394.00

 

Your Price : Log In

photo_fpc
BCR Pathway H384

Predesigned 384-well panel for use with SYBR® Green

 

List Price:  $523.00

 

Your Price : Log In

BCR signaling pathway

The BCR (B-Cell antigen Receptor) plays a critical role in development, survival, and activation of B lymphocytes. The BCR is composed of membrane immunoglobulin (IgM) molecules associated with CD79a molecule, immunoglobulin-associated alpha - CD79b molecule, immunoglobulin-associated beta heterodimers (CD79 complex) [1]. The IgM subunits bind antigens and cause receptor aggregation, while the CD79 complex subunits transduce intracellular signaling cascades. Upon activation, BCRs activate the Spleen tyrosine kinase (Syk) and v-yes-1 Yamaguchi sarcoma viral related oncogene homolog (Lyn), which phosphorylate and activate Phospholipases C, gamma (PLC-gamma), and Bruton agammaglobulinemia tyrosine kinase (BTK), respectively. BTK also activates both PLC-gamma isoforms [2], [3].

Once activated, these tyrosine kinases phosphorylate activate several signaling pathways, including Ras-ERK and PLC-gamma signal cascades, which lead to the activation of transcription factors, such as ELK1, member of ETS oncogene family (ELK1), Early growth response 1 (EGR1), Nuclear factor of activated T-cells, cytoplasmic, calcineurin-dependent 2 (NF-AT1(NFATC2)) and Nuclear factor of kappa light polypeptide gene enhancer in B-cells (NF-kB), and inhibit transcription factors, such as B-cell CLL/lymphoma 6 (Bcl-6).

PLC-gamma activation that is mediated by BTK and B-cell linker (BLNK), leads to the conversion of phosphatidylinositol-4,5-biphosphate (PtdIns(4,5)P2) to the second messengers inositol-1,4,5-trisphosphate (IP3) and Diacylglycerol (DAG). IP3 binds to Inositol 1,4,5-triphosphate receptor (IP3 Receptor), which is localized primarily on the endoplasmic reticulum and stimulates the release of calcium from intracellular stores. Calcium-bound Calmodulin 2 (Calmodulin) associates with and activates Protein phosphatase 3, catalytic subunit (Calcineurin A (catalytic)). Calcineurin A (catalytic) dephosphorylates NF-AT1(NFATC2) leading to theirs translocation to the nucleus [4].

DAG activates Protein kinase C, beta (PKC-beta). PKC-beta in particular, is a critical component of the BCR signalosome, and is essential for recruitment and activation of the IKK complex resulting in the translocation of NF-kB to the nucleus [5].

Several transmembrane receptors are known to modulate specific elements of BCR signaling. These include Protein tyrosine phosphatase, receptor type, C (CD45) and Fc fragment of IgG, low affinity IIb, receptor (Fc gamma RII beta).CD45 has its own protein tyrosine phosphatase activity and inhibits v-yes-1 Yamaguchi sarcoma viral related oncogene homolog (Lyn) activity by dephosphorylation leading to reduction in CD45's negative regulatory effects [6], [7].

Lyn phosphorylates and activates co-receptor CD19 molecule (CD19) and receptor Fc-gamma-RII [8], [9]. CD19 is a cell surface molecule, which assembles with the antigen receptor of B lymphocytes in order to decrease the threshold for antigen receptor-dependent stimulation. This co-receptor complex is composed of CD19, Complement component receptor 2 (CD21) and CD81 molecule (CD81) [10]. CD21 binds to opsinized antigenic particles and is primarily responsible for signal transduction. Phosphorylation of CD19 by Lyn generates binding sites for Phosphoinositide-3-kinase, catalytic (PI3K cat class IA). PI3K cat class IA activates Phosphatidylinositol-3,4,5-triphosphate (PtdIns(3,4,5)P3) and Vav 1 and 2 guanine nucleotide exchange factors (VAV-1 and VAV-2). The CD19 co-receptor physically interacts with VAV-1 and VAV-2 and synergistically enhances their phosphorylation induced by the BCR. VAV-1 and VAV-2 activate small GTP binding proteins Ras-related C3 botulinum toxin substrate 1 (Rac1) and cell division cycle 42 (CDC42) [11].

PtdIns(3,4,5)P3 associates with the inner phospholipid bilayer of the plasma membrane to promote the recruitment of pleckstrin homology (PH) domain-rich proteins such as 3-phosphoinositide dependent protein kinase-1 (PDK (PDPK1)) and V-akt murine thymoma viral oncogene homolog 1 (AKT(PKB)). PDK (PDPK1) activates AKT(PKB), which phosphorylates downstream target including BCL2 Antagonist of Cell Death (BAD), Glycogen synthase kinase 3 beta (GSK3 beta) and Ribosomal protein S6 kinase, 70kDa, polypeptide 1 (P70 S6 kinase1), thereby regulating apoptosis, cell cycle, cell growth and other cellular processes [12].

Fc-gamma-RII activates the Inositol polyphosphate-5-phosphatase, 145kDa (SHIP). SHIP converts PtdIns(3,4,5)P3 into PtdIns (3,4)P2, which is the second messenger that activates PDK (PDPK1) and AKT(PKB) [13].

Lyn also participates in the negative regulation of BCR signaling. Lyn phosphorylates CD22 molecule (CD22), which binds to the Protein tyrosine phosphatase, non-receptor type 6 (SHP-1) and induces Lyn dephosphorylation by SHP-1, thereby down-regulating Btk-dependent IP3 production and calcium mobilization [14], [15].

References:

  1. Geisberger R, Crameri R, Achatz G
    Models of signal transduction through the B-cell antigen receptor. Immunology 2003 Dec;110(4):401-10
  2. Pao LI, Cambier JC
    Syk, but not Lyn, recruitment to B cell antigen receptor and activation following stimulation of CD45- B cells. Journal of immunology (Baltimore, Md. : 1950) 1997 Mar 15;158(6):2663-9
  3. Mohamed AJ, Nore BF, Christensson B, Smith CI
    Signalling of Bruton's tyrosine kinase, Btk. Scandinavian journal of immunology 1999 Feb;49(2):113-8
  4. Hogan PG, Chen L, Nardone J, Rao A
    Transcriptional regulation by calcium, calcineurin, and NFAT. Genes & development 2003 Sep 15;17(18):2205-32
  5. Guo B, Su TT, Rawlings DJ
    Protein kinase C family functions in B-cell activation. Current opinion in immunology 2004 Jun;16(3):367-73
  6. Harashima A, Suzuki M, Okochi A, Yamamoto M, Matsuo Y, Motoda R, Yoshioka T, Orita K
    CD45 tyrosine phosphatase inhibits erythroid differentiation of umbilical cord blood CD34+ cells associated with selective inactivation of Lyn. Blood 2002 Dec 15;100(13):4440-5
  7. Shrivastava P, Katagiri T, Ogimoto M, Mizuno K, Yakura H
    Dynamic regulation of Src-family kinases by CD45 in B cells. Blood 2004 Feb 15;103(4):1425-32
  8. Malbec O, Fong DC, Turner M, Tybulewicz VL, Cambier JC, Fridman WH, Daeron M
    Fc epsilon receptor I-associated lyn-dependent phosphorylation of Fc gamma receptor IIB during negative regulation of mast cell activation. Journal of immunology (Baltimore, Md. : 1950) 1998 Feb 15;160(4):1647-58
  9. Somani AK, Yuen K, Xu F, Zhang J, Branch DR, Siminovitch KA
    The SH2 domain containing tyrosine phosphatase-1 down-regulates activation of Lyn and Lyn-induced tyrosine phosphorylation of the CD19 receptor in B cells. The Journal of biological chemistry 2001 Jan 19;276(3):1938-44
  10. Mongini PK, Jackson AE, Tolani S, Fattah RJ, Inman JK
    Role of complement-binding CD21/CD19/CD81 in enhancing human B cell protection from Fas-mediated apoptosis. Journal of immunology (Baltimore, Md. : 1950) 2003 Nov 15;171(10):5244-54
  11. O'Rourke LM, Tooze R, Turner M, Sandoval DM, Carter RH, Tybulewicz VL, Fearon DT
    CD19 as a membrane-anchored adaptor protein of B lymphocytes: costimulation of lipid and protein kinases by recruitment of Vav. Immunity 1998 May;8(5):635-45
  12. Katso R, Okkenhaug K, Ahmadi K, White S, Timms J, Waterfield MD
    Cellular function of phosphoinositide 3-kinases: implications for development, homeostasis, and cancer. Annual review of cell and developmental biology 2001;17:615-75
  13. Lemmon MA
    Phosphoinositide recognition domains. Traffic (Copenhagen, Denmark) 2003 Apr;4(4):201-13
  14. Fluckiger AC, Li Z, Kato RM, Wahl MI, Ochs HD, Longnecker R, Kinet JP, Witte ON, Scharenberg AM, Rawlings DJ
    Btk/Tec kinases regulate sustained increases in intracellular Ca2+ following B-cell receptor activation. The EMBO journal 1998 Apr 1;17(7):1973-85
  15. Poe JC, Fujimoto Y, Hasegawa M, Haas KM, Miller AS, Sanford IG, Bock CB, Fujimoto M, Tedder TF
    CD22 regulates B lymphocyte function in vivo through both ligand-dependent and ligand-independent mechanisms. Nature immunology 2004 Oct;5(10):1078-87

Target Details

Click on a target from the pathway image to view related information.

[ Close ]
Click here to print
[ Close ]
Click here to print
 

undefined

undefined

My PrimePCR Hot List stores your saved PrimePCR products and configurations

undefined

undefined

undefined

My PrimePCR Hot List stores your saved PrimePCR products and configurations

undefined

undefined

undefined

My PrimePCR Hot List stores your saved PrimePCR products and configurations

undefined

undefined

undefined

My PrimePCR Hot List stores your saved PrimePCR products and configurations

undefined

undefined

undefined

My PrimePCR Hot List stores your saved PrimePCR products and configurations

undefined

undefined

undefined

My PrimePCR Hot List stores your saved PrimePCR products and configurations

undefined